Life after patent: Drug price dynamics and cost-effectiveness analysis
Serra-Burriel, M.; Martin-Bassols, N.; Perenyi, G.; Vokinger, K. N.
Show abstract
This study analyzed the effects of patent expiration on drug prices in eight countries (US, UK, Cana-da, Australia, Japan, France, Germany, and Switzerland) and the impact of these price dynamics in cost-effectiveness assessments. First, using an event study design, we showed that average prices of drugs substantially decreased eight years after patent expiration. Then, to assess the implications of this finding for cost-effectiveness assessments, a theoretical cost-effectiveness model simulated two real-world scenarios: (1) the comparator drug was a generic and the patent of the new drug expired after market entry; (2) the comparator drug was also under patent protection, but the patent expired prior to the patent of the new drug. Not accounting for genericization or patent expiration of the com-parator drug resulted in an underestimation or overestimation of the incremental cost-effectiveness ratios, respectively. Our pricing dynamic estimates can be applied to base-case analyses of cost-effectiveness models.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Applying Historical Data in a Nonlinear Mixed-Effects Model Can Reduce the Number of Control Rats Required for Calculation of the Relative Potency of Insulin Analogues 92%
- Significant Relaxation of SARS-CoV-2-Targeted Non-Pharmaceutical Interventions Will Result in Profound Mortality: A New York State Modelling Study 92%
- Title-Impact of combined medication payment management policies on population health performance 92%
Similar papers in this journal
Similar papers in this journal
- Modelling vaccination capacity at mass vaccination hubs and general practice clinics 88%
- Utilization of health care services before and after media attention about fatal side effects of the AstraZeneca vaccine: a nation-wide register-based event study 88%
- Educational interventions delivered to prescribing advisers to influence primary care prescribing: a very low-cost pragmatic randomised trial using routine data from OpenPrescribing.net 88%
Similar papers in this journal
- Pricing Treatments Cost-Effectively When They Have Multiple Indications: Not Just a Simple Threshold Analysis 92%
- Multilevel and Quasi Monte Carlo methods for the calculation of the Expected Value of Partial Perfect Information 89%
- A Tutorial on Discrete Event Simulation Models in R Using a Cost-Effectiveness Analysis Example 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.